These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9600074)
1. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. Igarashi K; Isohara T; Kato T; Shigeta K; Yamano T; Uno I Biochem Biophys Res Commun; 1998 May; 246(1):95-9. PubMed ID: 9600074 [TBL] [Abstract][Full Text] [Related]
2. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. Cunningham SA; Arrate MP; Brock TA; Waxham MN Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617 [TBL] [Abstract][Full Text] [Related]
3. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. Roche S; McGlade J; Jones M; Gish GD; Pawson T; Courtneidge SA EMBO J; 1996 Sep; 15(18):4940-8. PubMed ID: 8890167 [TBL] [Abstract][Full Text] [Related]
4. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes. Ross SA; Lienhard GE; Lavan BE Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156 [TBL] [Abstract][Full Text] [Related]
5. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. Ito N; Wernstedt C; Engström U; Claesson-Welsh L J Biol Chem; 1998 Sep; 273(36):23410-8. PubMed ID: 9722576 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the VEGF binding site on the Flt-1 receptor. Herley MT; Yu Y; Whitney RG; Sato JD Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394 [TBL] [Abstract][Full Text] [Related]
7. The use of the yeast two hybrid system to evaluate ErbB-3 interactions with SH2 domain containing proteins. Yoo JY; Hamburger AW Biochem Biophys Res Commun; 1998 Oct; 251(3):903-6. PubMed ID: 9791008 [TBL] [Abstract][Full Text] [Related]
8. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. Sawano A; Takahashi T; Yamaguchi S; Shibuya M Biochem Biophys Res Commun; 1997 Sep; 238(2):487-91. PubMed ID: 9299537 [TBL] [Abstract][Full Text] [Related]
9. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385 [TBL] [Abstract][Full Text] [Related]
10. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. Roskoski R Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412 [TBL] [Abstract][Full Text] [Related]
11. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts. Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492 [TBL] [Abstract][Full Text] [Related]
12. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165 [TBL] [Abstract][Full Text] [Related]
13. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor. Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227 [TBL] [Abstract][Full Text] [Related]
14. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344 [TBL] [Abstract][Full Text] [Related]
15. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Poole AW; Jones ML Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691 [TBL] [Abstract][Full Text] [Related]
16. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. Takahashi T; Yamaguchi S; Chida K; Shibuya M EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210 [TBL] [Abstract][Full Text] [Related]
18. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis. Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005 [TBL] [Abstract][Full Text] [Related]
19. Sck interacts with KDR and Flt-1 via its SH2 domain. Igarashi K; Shigeta K; Isohara T; Yamano T; Uno I Biochem Biophys Res Commun; 1998 Oct; 251(1):77-82. PubMed ID: 9790910 [TBL] [Abstract][Full Text] [Related]
20. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]